May 31 (Reuters) - Novan Inc :
* NOVAN FOCUSES STRATEGIC DIRECTION AND ANNOUNCES RESTRUCTURING
* NOVAN INC - DIRECTING RESOURCES ON POTENTIAL APPROVAL OF BERDAZIMER GEL, 10.3% (SB206) FOR MOLLUSCUM CONTAGIOSUM
* NOVAN INC - PROCESS TO EXPLORE A SALE OR OUT-LICENSE OF COMMERCIAL ASSETS OR OTHER BUSINESS TRANSACTION CONTINUES
* NOVAN INC - CONTINUED PROGRESS TOWARD PDUFA GOAL DATE OF JANUARY 5, 2024, FOR BERDAZIMER GEL, 10.3%
* NOVAN INC - CONTINUED PROGRESS TOWARD PDUFA GOAL DATE OF JANUARY 5, 2024, FOR BERDAZIMER GEL, 10.3%
* NOVAN INC - WILL IMMEDIATELY REDUCE CERTAIN OF ITS OPERATING EXPENSES CURRENTLY SUPPORTING ITS COMMERCIAL OPERATIONS.
* NOVAN - TO SELL AND DISTRIBUTE COMMERCIAL PRODUCTS, INCUR CERTAIN RELATED EXPENSES ASSOCIATED WITH RHOFADE, WYNZORA, MINOLIRA, CLODERM IN U.S.
* NOVAN - EXISTING CASH AND CASH EQUIVALENTS AS OF MARCH 31 TO PROVIDE CO WITH LIQUIDITY TO FUND PLANNED OPERATIONS INTO LATE JUNE
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。